Table 5.

Post-transplant complications according to telomere dysfunction and time after lung transplantation.

Type of post-transplant complications	First 24 h		During the first month		After the first month
	Telomere shortening	No telomere shortening	Telomere shortening	No telomere shortening	Telomere shortening	No telomere shortening
Endocrine (n, %)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	8 (67)	7 (88)
Post-transplant CMV replication (n, %)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	7 (58)	7 (88)
Infectious (n, %)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	6 (50)	6 (75)
Allograft dysfunction (n, %)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	3 (25)	5 (62)
Hemodynamic dysfunction (n, %)	4 (33)	3 (38)	3 (25)	3 (38)	0 (0.0)	0 (0.0)
Hematological (n, %)	4 (33)	0 (0.0)	2 (17)	0 (0.0)	4 (33)	2 (25)
Mechanical (n, %)	3 (25)	3 (38)	2 (17)	3 (38)	0 (0.0)	0 (0.0)
Primary graft dysfunction (n, %)	2 (17)	1 (12)	2 (17)	1 (12)	0 (0.0)	0 (0.0)
Donor lung infection (n, %)	0 (0.0)	1 (12)	0 (0.0)	1 (12)	0 (0.0)	0 (0.0)
Atrial fibrillation (n, %)	2 (17)	0 (0.0)	1 (8)	0 (0.0)	0 (0.0)	0 (0.0)
Renal (n, %)	1 (8)	1 (12)	0 (0.0)	0 (0.0)	4 (33)	3 (38)
Miopathy of critical patient (n, %)	1 (8)	0 (0.0)	1 (8)	0 (0.0)	0 (0.0)	0 (0.0)